References

1. Knops RE, Olde Nordkamp LRA, Delnoy P-PHM, et al. Subcutaneous or Transvenous Defibrillator Therapy. N Engl J Med . 2020;383(6):526-536. doi:10.1056/nejmoa1915932
2. Narula OS, Scherlag BJ, Samet P. Pervenous pacing of the specialized conducting system in man. His bundle and A-V nodal stimulation.Circulation . 1970;41(1):77-87. doi:10.1161/01.CIR.41.1.77
3. Zanon F, Ellenbogen KA, Dandamudi G, Sharma PS, Huang W, Lustgarten DL, Tung R, Tada H, Koneru JN, Bergemann T, Fagan DH, Hudnall JH, Vijayaraman P. Permanent His-bundle pacing: A systematic literature review and meta-analysis. Europace . 2018;20(11):1819-1826. doi:10.1093/europace/euy058
4. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy - Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC). Eur Heart J . 2021;42(35):3427–3520. doi:10.1093/eurheartj/ehab364
5. Curtis AB, Worley SJ, Adamson PB, Chung ES, Niazi I, Sherfesee L, Shinn T, St. John Sutton M. Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction. N Engl J Med . 2013;368(17):1585-1593. doi:10.1056/nejmoa1210356
6. Zweerink A, Zubarev S, Bakelants E, Potyagaylo D, Stettler C, Chmelevsky M, Lozeron ED, Hachulla AL, Vallée JP, Burri H. His-Optimized Cardiac Resynchronization Therapy With Ventricular Fusion Pacing for Electrical Resynchronization in Heart Failure. JACC Clin Electrophysiol . 2021;7(7):881-892. doi:10.1016/j.jacep.2020.11.029
7. Kutyifa V, Rosero SZ, McNitt S, Polonsky B, Brown MW, Zareba W, Goldenberg I. Need for pacing in patients who qualify for an implantable cardioverter-defibrillator: Clinical implications for the subcutaneous ICD. Ann Noninvasive Electrocardiol . 2020;25(4):e12744. doi:10.1111/anec.12744
8. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J . 2021;42(36):3599–3726. doi:10.1002/ejhf.2333
9. Huang J, Patton KK, Prutkin JM. Concomitant Use of the Subcutaneous Implantable Cardioverter Defibrillator and a Permanent Pacemaker.PACE - Pacing Clin Electrophysiol . 2016;39(11):1240-1245. doi:10.1111/pace.12955
10. Porterfield C, Dimarco JP, Mason PK. Effectiveness of implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with complete heart block and a pacemaker. Am J Cardiol . 2015;115(2):276-278. doi:10.1016/j.amjcard.2014.10.036
11. Kajiyama T, Kondo Y, Nakano M, Chiba T, Kobayashi Y. Concomitant use and interaction of a subcutaneous implantable defibrillator and epicardial pacemaker. J Arrhythmia . 2022;38(1):155-156. doi:10.1002/joa3.12666
12. Ishii N, Nakajima K, Kakuta T, Noda T, Fujita T, Kusano K. One indication for an extravascular cardiac resynchronization therapy defibrillator: Lessons from a combination therapy case with epicardial cardiac resynchronization therapy and a subcutaneous implantable cardioverter defibrillator. Intern Med . 2021;60(12):1877-1880. doi:10.2169/internalmedicine.6125-20
13. Gauthey A, Calle S, Accinelli S, Depuydt P, Garnir Q, Scavée C, Marchandise S, Wauters A, Bordachar P, de Pooter J, de Waroux JB le P. His bundle pacing for newly acquired pacing needs in patients implanted with a subcutaneous implantable cardioverter defibrillator: A feasibility study based on the automated screening score and clinical cases. J Cardiovasc Electrophysiol . 2020;31(7):1793-1800. doi:10.1111/jce.14566
14. Fernández-Palacios G, García-Morán E, Sandín-Fuentes M, García-Granja PE, Rubio J, San Román AJ. The utility of a combined synchronous atrioventricular leadless pacemaker and subcutaneous implantable cardiac defibrillator system in bilateral upper limb venous occlusion. Europace . 2021;23(5):814. doi:10.1093/europace/euaa332
15. Breeman KTN, Swackhamer B, Brisben AJ, Quast AFBE, Carter N, Shuros A, Soltis B, Koop BE, Burke MC, Wilde AAM, Tjong FVY, Knops RE. Long-term performance of a novel communicating antitachycardia pacing–enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: A comprehensive preclinical study.Hear Rhythm . 2022;19(5). doi:10.1016/j.hrthm.2022.01.024
16. Elliott MK, Sidhu BS, Mehta VS, Gould J, Martic D, Rinaldi CA. The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems. Hear Case Reports . 2021;7(9):628-632. doi:10.1016/j.hrcr.2021.06.006
17. Nabavizadeh P, Rajsheker S, Attari M. Hybrid subcutaneous and transvenous approach for cardiac resynchronization defibrillator implant in a patient with congenital heart disease and tricuspid bioprosthetic.Hear Case Reports . 2020;6(1):27-28. doi:10.1016/j.hrcr.2019.10.008
18. Srinivasan NT, Segal OR. Biventricular pacing and coronary sinus ICD lead implantation in a patient with a mechanical tricuspid valve replacement. J Cardiol Cases . 2015;12(6):180-182. doi:10.1016/j.jccase.2015.08.004
19. Lüker J, Sultan A, Sreeram N, Brockmeier K, Steven D. Implantation of a subcutaneous implantable cardioverter defibrillator with right parasternal electrode position in a patient with D-transposition of the great arteries and concomitant AAI pacemaker: A case report. Eur Hear J - Case Reports . 2018;2(3). doi:10.1093/ehjcr/yty099
20. van Opstal J, Geskes G, Debie L. A completely subcutaneous implantable cardioverter defibrillator system functioning simultaneously with an endocardial implantable cardioverter defibrillator programmed as pacemaker. Europace . 2011;13(1):141-142. doi:10.1093/europace/euq187
21. Marzak H, Morel O, Jesel L. Inappropriate shock due to quadruple counting in a patient with subcutaneous implantable cardioverter-defibrillator and a dual-chamber pacemaker.Europace . 2020;22(5):796. doi:10.1093/europace/euaa028
22. Kossidas K, Kalman R, Follis WP, Cooper JM. Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system. Hear Case Reports . 2017;3(12):579-583. doi:10.1016/j.hrcr.2017.08.004
23. Ip JE, Wu MS, Kennel PJ, Thomas G, Liu CF, Cheung JW, Markowitz SM, Lerman BB. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators. J Cardiovasc Electrophysiol . 2017;28(5):544-548. doi:10.1111/jce.13182
24. Giammaria M, Lucciola MT, Amellone C, Orlando F, Mazzone G, Chiarenza S, Lovecchio M, Valsecchi S. Eligibility of cardiac resynchronization therapy patients for subcutaneous implantable cardioverter defibrillators. J Interv Card Electrophysiol . 2019;54(1):49-54. doi:10.1007/s10840-018-0437-9
25. Jing R, Jin H, Hua W, Yang S, Hu Y, Zhang S. Association between subcutaneous implantable cardioverter defibrillator preimplantation screening and the response to cardiac resynchronization therapy.Korean Circ J . 2020;50(12). doi:10.4070/KCJ.2019.0420